Humana (NYSE:HUM) Receives “Outperform” Rating from Royal Bank of Canada

Humana (NYSE:HUM)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank of Canada in a note issued to investors on Wednesday,Benzinga reports. They presently have a $283.00 price objective on the insurance provider’s stock. Royal Bank of Canada’s target price indicates a potential upside of 11.90% from the company’s current price.

A number of other research analysts have also commented on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and upped their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Wells Fargo & Company lowered their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Morgan Stanley lowered their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, Piper Sandler upped their target price on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Nineteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $293.05.

Humana Stock Down 2.7 %

Humana stock opened at $252.92 on Wednesday. The firm has a fifty day moving average price of $272.44 and a two-hundred day moving average price of $295.47. The firm has a market cap of $30.45 billion, a price-to-earnings ratio of 22.40, a P/E/G ratio of 2.11 and a beta of 0.56. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, analysts forecast that Humana will post 16.11 earnings per share for the current year.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.32% of the stock is currently owned by company insiders.

Institutional Trading of Humana

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Global Endowment Management LP increased its holdings in shares of Humana by 7.7% in the fourth quarter. Global Endowment Management LP now owns 1,827 shares of the insurance provider’s stock valued at $464,000 after purchasing an additional 131 shares in the last quarter. Insigneo Advisory Services LLC boosted its stake in Humana by 17.3% in the fourth quarter. Insigneo Advisory Services LLC now owns 1,360 shares of the insurance provider’s stock valued at $345,000 after acquiring an additional 201 shares during the last quarter. Dodge & Cox boosted its stake in Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock valued at $2,587,345,000 after acquiring an additional 5,264,045 shares during the last quarter. CacheTech Inc. boosted its stake in Humana by 24.3% in the fourth quarter. CacheTech Inc. now owns 9,717 shares of the insurance provider’s stock valued at $2,465,000 after acquiring an additional 1,899 shares during the last quarter. Finally, AGP Franklin LLC bought a new position in Humana in the fourth quarter valued at approximately $1,506,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.